-
TUV Rheinland Greater China Opens First Eyewear Lab in Shenzhen
en-cphi.cn
July 03, 2017
On June 2, TUV Rheinland opened its first and only eyewear laboratory in Greater China based in Shenzhen.
-
Concord Medical To Install Proton Therapy System at Guangzhou Concord Cancer Hospital
en-cphi.cn
July 03, 2017
Concord Medical Services Holdings Limited is pleased to announce that on June 29, 2017 its subsidiary, Guangzhou Concord Cancer Hospital Ltd., entered into an agreement with Varian Medical Systems Particle Therapy
-
CHINA AID: one of the most authoritative elderly and long-term care events in China
en-cphi.cn
July 03, 2017
The 13th China International Exhibition of Senior Care, Rehabilitation Medicine and Healthcare (CHINA AID ) will take place from 28th to 30th May 2018 at the Shanghai New International Expo Centre.
-
Chinese “Legend” Talking about the Starry CAR-T Products on ASCO with Global CAR-T Giants
en-cphi.cn
June 30, 2017
The ASCO (American Society of Clinical Oncology) Annual Meeting—an annual event on oncology, was successfully concluded in the beautiful McCormick Place, Chicago on June 6, 2017.
-
Concord Medical Announces Construction of Proton Treatment Building of Beijing Proton Medical Center
en-cphi.cn
June 30, 2017
Concord Medical Services Holdings Limited announced that the proton treatment building of the Beijing Proton Medical Center officially started construction.
-
China-US investors fund Vivace Therapeutics
biospectrumasia
June 30, 2017
The company brings together leading scientists, investors and executives from the U.S. and China for a capital-efficient approach to developing novel cancer treatments.
-
Zai Lab Secures Series C Financing
en-cphi.cn
June 29, 2017
Zai Lab Limited, a Shanghai-based innovative biopharmaceutical company focused on discovering or licensing, developing and commercializing proprietary therapeutics that address areas of large unmet medical needs in the China market.
-
Shimadzu expands joint research in China
biospectrumasia
June 29, 2017
The Japanese manufacturer aims to have 120 joint research laboratories in three years, up from around 80 presently.
-
China’s iCarbonX invests in funding HealthLoop
biospectrumasia
June 29, 2017
iCarbonX plans to integrate HealthLoop’s patients-generated data to advance its data mining technology and help establish its digital life ecosystem.
-
NeuroVive and Yungjin Pharm Start Clinical Development in Genetic Mitochondrial Disease
en-cphi.cn
June 28, 2017
NeuroVive Pharmaceutical AB (Nasdaq Stockholm: NVP, OTCQX: NEVPF) and Yungjin Pharm Corporation Ltd (South Korea Stock Market, KRX 003520) today announced that the clinical phase I study of KL1333 has started in Korea and that the first healthy volunteer